{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:05:24Z","timestamp":1778605524825,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jcpo.2023.100423","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T21:00:34Z","timestamp":1681765234000},"page":"100423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials?"],"prefix":"10.1016","volume":"36","author":[{"given":"Timoth\u00e9e","family":"Olivier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcpo.2023.100423_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jcpo.2023.100423_bib2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jnci\/djab192","article-title":"Annual report to the nation on the status of Cancer, Part 2: patient economic burden associated with cancer care","volume":"113","author":"Yabroff","year":"2021","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"20","key":"10.1016\/j.jcpo.2023.100423_bib3","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/cncr.28262","article-title":"Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?","volume":"119","author":"Kent","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jcpo.2023.100423_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial burdens of cancer treatment: a systematic review of risk factors and outcomes","volume":"17","author":"Smith","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.jcpo.2023.100423_bib5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey","year":"2013","journal-title":"Health Aff. Proj. Hope"},{"issue":"9","key":"10.1016\/j.jcpo.2023.100423_bib6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"33","key":"10.1016\/j.jcpo.2023.100423_bib7","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1200\/JCO.18.01132","article-title":"Addressing financial barriers to patient participation in clinical trials: ASCO policy statement","volume":"36","author":"Winkfield","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.jcpo.2023.100423_bib8","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1200\/JCO.2014.57.8740","article-title":"Reporting and grading financial toxicity","volume":"32","author":"Khera","year":"2014","journal-title":"J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jcpo.2023.100423_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jcpo.2023.100423_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049128","article-title":"Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system","volume":"11","author":"Riva","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jcpo.2023.100423_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpainsymman.2019.05.011","article-title":"Financial strain and physical and emotional quality of life in breast cancer","volume":"58","author":"Perry","year":"2019","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.jcpo.2023.100423_bib12","doi-asserted-by":"crossref","unstructured":"Correlation Between Financial Toxicity, Quality of Life, and Patient Satisfaction in an Insured Population of Breast Cancer Surgical Patients: A Single-Institution Retrospective Study. J Am Coll Surg. 2021 Mar 1;232(3):253\u2013263.","DOI":"10.1016\/j.jamcollsurg.2020.10.023"},{"issue":"3","key":"10.1016\/j.jcpo.2023.100423_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jamcollsurg.2020.10.023","article-title":"Correlation between financial toxicity, quality of life, and patient satisfaction in an insured population of breast cancer surgical patients: a single-institution retrospective study","volume":"232","author":"Coroneos","year":"2021","journal-title":"J. Am. Coll. Surg."},{"issue":"12","key":"10.1016\/j.jcpo.2023.100423_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25810","article-title":"Assessment of financial toxicity among older adults with advanced cancer","volume":"3","author":"Arastu","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.jcpo.2023.100423_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pon.5763","article-title":"Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors","volume":"31","author":"Benedict","year":"2022","journal-title":"Psychooncology"},{"key":"10.1016\/j.jcpo.2023.100423_bib16","unstructured":"Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics. 2018;19."},{"key":"10.1016\/j.jcpo.2023.100423_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jclinepi.2021.07.013","article-title":"Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials","volume":"139","author":"Olivier","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.jcpo.2023.100423_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.jcpo.2023.100423_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(19)30272-4","article-title":"Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study","volume":"20","author":"Bekaii-Saab","year":"2019","journal-title":"Lancet Oncol."},{"issue":"13","key":"10.1016\/j.jcpo.2023.100423_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell Carcinoma of the head and neck: the randomized phase III TROG 05.01 trial","volume":"36","author":"Porceddu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2023.100423_bib21","unstructured":"scoring_of_the_qlq-c30_summary_score.pdf [Internet]. [cited 2023 Feb 18]. Available from: \u3008https:\/\/qol.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/scoring_of_the_qlq-c30_summary_score.pdf\u3009."},{"key":"10.1016\/j.jcpo.2023.100423_bib22","unstructured":"Global Cancer Spending Reaches $100B [Internet]. [cited 2022 Aug 16]. Available from: \u3008https:\/\/www.usnews.com\/news\/blogs\/data-mine\/2015\/05\/05\/global-cancer-spending-reaches-100b\u3009."},{"key":"10.1016\/j.jcpo.2023.100423_bib23","unstructured":"Global Oncology Trends 2022 [Internet]. [cited 2022 Aug 16]. Available from: \u3008https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/global-oncology-trends-2022\u3009."},{"key":"10.1016\/j.jcpo.2023.100423_bib24","unstructured":"Protections (OHRP) O for HR. Attachment A - Addressing Ethical Concerns Offers of Payment to Research Participants [Internet]. HHS.gov. 2019 [cited 2022 Aug 24]. Available from: \u3008https:\/\/www.hhs.gov\/ohrp\/sachrp-committee\/recommendations\/attachment-a-september-30\u20132019\/index.html\u3009."},{"issue":"3","key":"10.1016\/j.jcpo.2023.100423_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0363","article-title":"Patient experience captured by quality-of-life measurement in oncology clinical trials","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.jcpo.2023.100423_bib26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","article-title":"The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy","volume":"27","author":"Perrone","year":"2016","journal-title":"Ann. Oncol. Off J. Eur. SocMed. Oncol."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538323000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538323000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:08:11Z","timestamp":1761988091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538323000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":26,"alternative-id":["S2213538323000401"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2023.100423","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2023.100423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100423"}}